Revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016 (in million U.S. dollars)

Top U.S. pharmaceutical patent expiries by revenue 2014-2016 This statistic displays revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016. Otsuka's Abilify's U.S. patent will expire in April 2015 and its revenue is expected to drop from almost 3.8 billion U.S. dollars in 2014 down to 334 million U.S. dollars in 2016.
Show more
Loading statistic...
Product (patent expiry date)201420152016
Abilify (April 2015)3,7791,789334
Copaxone (May 2014)2,7472,0911,814
Zyvox (May 2015)689364110
Tracleer (November 2015)553398157
Avodart (November 2015)47740370
Product (patent expiry date)201420152016
Abilify (April 2015)3,7791,789334
Copaxone (May 2014)2,7472,0911,814
Zyvox (May 2015)689364110
Tracleer (November 2015)553398157
Avodart (November 2015)47740370
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic displays revenue losses of leading pharmaceutical products due to patent expiries in the U.S. from 2014 to 2016. Otsuka's Abilify's U.S. patent will expire in April 2015 and its revenue is expected to drop from almost 3.8 billion U.S. dollars in 2014 down to 334 million U.S. dollars in 2016.
Show more
Release date
December 2014
Region
United States
Survey time period
December 2014
Open this statistic in...

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:

Related Studies: Available to Download in PDF or PPTX Format

Pharmaceutical brands: Abilify (BMS/Otsuka)

All Information
in one Presentation

Pharmaceutical brands: Abilify (BMS/Otsuka)

Everything On "Pharmaceutical brands: Abilify (BMS/Otsuka)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical brands: Abilify (BMS/Otsuka)"

  • Overview
  • Drug prices and consumer behavior
  • Advertising expenditures
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

4 News

We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.